Table 1 Association of PODXL expression and clinicopathological parameters by polyclonal antibody HPA 2110
From: A comparative study of two PODXL antibodies in 840 colorectal cancer patients
PODXL expression | |||
|---|---|---|---|
Non-membranous | Membranous | ||
n (%) | 717 (91.9) | 63 (8.1) | p-value |
Age, years | |||
<65 | 299 (41.7) | 32 (50.8) | 0.184 |
≥ 65 | 418 (48.3) | 31 (49.2) | |
Gender | |||
Male | 398 (55.5) | 31 (49.2) | 0.357 |
Female | 319 (44.5) | 32 (50.8) | |
Dukes | |||
A | 111 (15.5) | 2 (3.2) | < 0.001 |
B | 258 (36.0) | 17 (27.0) | |
C | 191 (26.6) | 22 (34.9) | |
D | 157 (21.9) | 22 (34.9) | |
Grade (WHO) | |||
1 | 27 (3.8) | 0 (0) | < 0.0001 |
2 | 511 (71.8) | 27 (42.9) | |
3 | 155 (21.8) | 30 (47.6) | |
4 | 19 (2.7) | 6 (9.5) | |
Missing | 5 | ||
Location | |||
Colon | 370 (51.6) | 35 (55.6) | 0.548 |
Rectum | 347 (48.4) | 28 (44.4) | |
Side | |||
Right | 193 (26.9) | 21 (33.3) | 0.274 |
Left | 542 (73.1) | 42 (66.7) | |
Histology | |||
Adenomatous | 644 (89.9) | 57 (90.5) | 1.000 |
Mucinous | 72 (10.1) | 6 (9.5) | |
Missing | 1 | ||